OPHID reaffirms support for Zim rollout of Lenacapavir—the twice-yearly HIV prevention shot. 💉
Dr. Pugie Chimberengwa says the injectable has already boosted male participation in prevention efforts. Zim is among the first globally to deploy LEN via national clinics.
Zimbabwe expands Lenacapavir rollout with 43 000 more doses
For these and other stories, watch #NewsPlus on #ZTNPrime, #DStv294 or https://t.co/4rpYJbSllF every Monday to Friday @ 7pm
#GetThePicture#Zimbabwe
Zimbabwe is set to dramatically scale up access to Lenacapavir, the long-acting injectable HIV prevention drug, after securing additional support from the Global Fund through the United States Department of State.
The new funding will add 43,000 more doses to Zimbabwe’s rollout programme, increasing the national target to approximately 46,500 users in 2026. Early uptake data already shows strong demand, especially among women and adults aged between 25 and 39 years, with health officials describing Lenacapavir as a “preferred prevention method” due to its convenience and long-acting protection.
Read the full story on HealthTimes:
https://t.co/2tfvCen44W
#Lenacapavir #HIVPrevention #Zimbabwe
@GileadSciences@GlobalFund@StateDept@MoHCCZim@UNAIDS@naczim@CWGH1@WHO_Zimbabwe@OPHID_Trust
SEAN WILLIAMS! Our Zimbabwean legend crosses the line for a magnificent century.
His fifth in test cricket and a phenomenal one for Zimbabwe.
Very proud! Onwards we go!
🌍 This #WorldAIDSDay2024 OPHID embraces the theme "Take the Right Path: My Health, My Right, Our Responsibility." Read our official statement to learn more about our initiatives & how we can all contribute to this cause. #WorldAIDSDay#MyHealthMyRightOurResponsibility